TET2 and cyclic hematopoiesis: We focused on DNMT3A and/or TET2 mutation carriers (n = 9,386) in the replication sample, stratified by these two genes and clone size, and evaluated the 20 unique lead variants identified in the discovery GWAS (representing 26 distinct overall/subtype-specific CH associations).